Nippon Express Obtains GDP Certification of Compliance with WHO Standards at East Japan Pharmaceutical Center

BY PR Newswire | ECONOMIC | 09/14/22 02:00 AM EDT

- Dedicated Pharmaceutical Logistics Facility Offers Storage and Transport in Two Temperature Ranges -

TOKYO, Sept. 14, 2022 /PRNewswire/ --?Nippon Express Co., Ltd. (hereafter "Nippon Express"), a group company of NIPPON EXPRESS HOLDINGS, INC., has acquired Good Distribution Practice (GDP) certification for its East Japan Pharmaceutical Center (Kuki City, Saitama Prefecture), effective July 29, evidencing its compliance with WHO standards for the proper distribution of pharmaceuticals.

Logo: https://kyodonewsprwire.jp/img/202209086166-O1-PLmZo0wX

Photo1: East Japan Pharmaceutical Center
https://kyodonewsprwire.jp/prwfile/release/M103866/202209086166/_prw_PI2fl_C7EUIGA5.jpg

Photo2: Dedicated pharmaceutical transport vehicle
https://kyodonewsprwire.jp/prwfile/release/M103866/202209086166/_prw_PI3fl_A7788l54.jpg

The Nippon Express Group has positioned the pharmaceutical industry as a key industry in its "Nippon Express Group Business Plan 2023 -- Dynamic Growth," and has been developing a safe and secure pharmaceutical logistics platform to meet sophisticated and diverse pharmaceutical logistics needs globally.

The East Japan Pharmaceutical Center has now obtained GDP certification of its conformity to WHO standards for the storage and transport of pharmaceutical products in two temperature ranges (room temperature "15 C -25 C" and refrigerated "2 C -8 C"). The Nippon Express Group has acquired GDP certifications for pharmaceutical logistics at 32 business locations in 24 countries/regions around the world (including two sites that have also acquired CEIV Pharma certification) and will continue providing safe and high-quality pharmaceutical logistics services on an end-to-end basis globally with these certifications at the heart of its services.

Going forward, the Nippon Express Group will be further strengthening its pharmaceutical initiatives, enhancing the value of pharmaceuticals through transport, and striving to improve quality and expand services to ensure pharmaceuticals reach those who need them and thereby contribute to their health.

Nippon Express website: https://www.nipponexpress.com/

Nippon Express Group's official LinkedIn account:
https://www.linkedin.com/company/nippon-express-group/

Cision View original content:https://www.prnewswire.com/news-releases/nippon-express-obtains-gdp-certification-of-compliance-with-who-standards-at-east-japan-pharmaceutical-center-301623891.html

SOURCE NIPPON EXPRESS HOLDINGS, INC.

In general the bond market is volatile, and fixed income securities carry interest rate risk. (As interest rates rise, bond prices usually fall, and vice versa. This effect is usually more pronounced for longer-term securities.) Fixed income securities also carry inflation risk and credit and default risks for both issuers and counterparties. Unlike individual bonds, most bond funds do not have a maturity date, so avoiding losses caused by price volatility by holding them until maturity is not possible.

Lower-quality debt securities generally offer higher yields, but also involve greater risk of default or price changes due to potential changes in the credit quality of the issuer. Any fixed income security sold or redeemed prior to maturity may be subject to loss.

Before investing, consider the funds' investment objectives, risks, charges, and expenses. Contact Fidelity for a prospectus or, if available, a summary prospectus containing this information. Read it carefully.

fir_news_article